Providence Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Buy |
17,452
+980
| +6% | +$182K | 0.59% | 65 |
|
|
2025
Q1 | $3.45M | Buy |
16,472
+204
| +1% | +$42.7K | 0.72% | 58 |
|
|
2024
Q4 | $2.89M | Buy |
16,268
+49
| +0.3% | +$8.71K | 0.59% | 68 |
|
|
2024
Q3 | $3.2M | Buy |
16,219
+118
| +0.7% | +$23.3K | 0.64% | 66 |
|
|
2024
Q2 | $2.76M | Buy |
16,101
+169
| +1% | +$29K | 0.6% | 68 |
|
|
2024
Q1 | $2.9M | Buy |
15,932
+184
| +1% | +$33.5K | 0.63% | 66 |
|
|
2023
Q4 | $2.44M | Sell |
15,748
-489
| -3% | -$75.8K | 0.59% | 68 |
|
|
2023
Q3 | $2.42M | Buy |
16,237
+106
| +0.7% | +$15.8K | 0.63% | 68 |
|
|
2023
Q2 | $2.17M | Buy |
16,131
+365
| +2% | +$49.2K | 0.55% | 72 |
|
|
2023
Q1 | $2.51M | Buy |
15,766
+576
| +4% | +$91.8K | 0.66% | 64 |
|
|
2022
Q4 | $2.45M | Buy |
15,190
+9
| +0.1% | +$1.45K | 0.66% | 68 |
|
|
2022
Q3 | $2.04M | Buy |
15,181
+302
| +2% | +$40.5K | 0.61% | 75 |
|
|
2022
Q2 | $2.28M | Sell |
14,879
-5,348
| -26% | -$819K | 0.66% | 76 |
|
|
2022
Q1 | $3.26M | Sell |
20,227
-3,057
| -13% | -$493K | 0.8% | 55 |
|
|
2021
Q4 | $3.15M | Buy |
23,284
+995
| +4% | +$135K | 0.87% | 50 |
|
|
2021
Q3 | $2.4M | Buy |
22,289
+7,075
| +47% | +$763K | 0.75% | 54 |
|
|
2021
Q2 | $1.71M | Buy |
15,214
+800
| +6% | +$90.1K | 0.55% | 65 |
|
|
2021
Q1 | $1.56M | Buy |
14,414
+689
| +5% | +$74.6K | 0.57% | 66 |
|
|
2020
Q4 | $1.47M | Buy |
13,725
+1,532
| +13% | +$164K | 0.6% | 64 |
|
|
2020
Q3 | $1.07M | Buy |
12,193
+509
| +4% | +$44.6K | 0.56% | 63 |
|
|
2020
Q2 | $1.15M | Buy |
+11,684
| New | +$1.15M | 0.65% | 60 |
|
|
2020
Q1 | – | Sell |
-116
| Closed | -$10K | – | 236 |
|
|
2019
Q4 | $10K | Buy |
+116
| New | +$10K | 0.01% | 176 |
|
|
2018
Q1 | – | Sell |
-150
| Closed | -$15K | – | 244 |
|
|
2017
Q4 | $15K | Buy |
+150
| New | +$15K | 0.01% | 172 |
|